JPRN-UMIN000032807已完成未知
Dupixent Special Drug Use Investigation for long term use - Dupixent Special Drug Use Investigation for long term use
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- Sanofi K.K.
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Subjects who are participating in or have been registered for clinical trials with therapeutic intervention to Dupixent
研究者
相似试验
尚未招募
Unknown
Dupixent Special Drug Use Investigation for long term use (Prurigo nodularis)Prurigo nodularisJPRN-UMIN000051970Sanofi K.K.100
尚未招募
Unknown
Dupixent Special Drug Use Investigation for long term use (Pediatric Atopic Dermatitis)Atopic DermatitisJPRN-UMIN000052375Sanofi K.K.70
已完成
不适用
Dupixent Specified Drug Use Investigation for long term use (Asthma)AsthmaJPRN-UMIN000036992Sanofi K.K.391
已完成
不适用
Special Drug Use-results survey for long-term administration of Stelarapsoriasis vulgaris, psoriatic arthritisJPRN-UMIN000015899Janssen Pharmaceutical K.K.1,500
已完成
不适用
Special Drug Use-results survey for long term administration of Reminyl 4mg/8mg/12mg Tablets, 4mg/8mg/12mg OD Tablets, 4mg/mL Oral SolutioMild to moderately severe dementia of the Alzheimer's typeJPRN-UMIN000017151Janssen Pharmaceutical K.K.600